Goldman Sachs Upgrades SXC Health Solutions (SXCI) to Buy, Sees 19% Upside

Article Stock Quotes (1) Comments (0)

Goldman Sachs upgraded SXC Health Solutions (NASDAQ: SXCI) to Buy with a price target of $86 (up from $71), suggesting 19% upside.

The firm said SXC Health will benefit meaningfully near-term in the current selling season and they see opportunity as it is still underappreciated despite positive EPS revision and recent stock outperformance.

As the company has grown revenue almost 6X over the 3 years, Goldman sees it more than doubling revenue by 2015.

For an analyst ratings summary and ratings history on SXC Health Solutions click here. For more ratings news on SXC Health Solutions click here.

Shares of SXC Health Solutions closed at $72.54 yesterday, with a 52 week range of $40.36-$74.37.

---

Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW

---

*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here

---

---

You May Also Be Interested In

• Hewlett-Packard (HPQ) Q2 Performance Wins Praise on Wall Street; Jefferies Raises to Hold
• Macquarie Upgrades CVR Energy (CVI) to Neutral
• Goldman Sachs Downgrades Aixtron (AIXG) to Neutral

Create E-mail Alert Related Categories

Analyst PT Change, Upgrades

Related Entities

Goldman Sachs

Add Your Comment

Name

Subject

Body

Share on Facebook

Verification
can't see the text?
click here to refresh the image.
what's this?